Institut Regional Du Cancer De Montpellier — Sponsor Intelligence | 10 EU Trials

Filter these 10 trials by condition, phase, country and more.

Open in Search →

10 Registered trials

5 Recruiting

2 Completed trials

1 Countries active

15 Unique IMPs

100% Results reported

Phase III

Phase II/III

Phase II

Phase III: 1 Phase II/III: 1 Phase II: 8

Oversight events:

1 temporary halt across 1 trial

View oversight register →

100%

2 of 2 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Breast cancer 1 Glioma 1

Top IMPs

FLUOROURACIL 1 GEMCITABINE 1 IRINOTECAN HYDROCHLORIDE TRIHYDRATE 1 L-LYSINE HYDROCHLORIDE, L-ARGININE HYDROCHLORIDE 1 LEVOLEUCOVORIN 1 LUTETIUM (177LU) OXODOTREOTIDE 1 OXALIPLATIN 1 PACLITAXEL ALBUMIN-BOUND 1 REGORAFENIB 1

All trials

10 total

Intensive Intraperitoneal Therapy in Advanced Ovarian Cancer Pending

2024-515339-30-00 Phase II 1 country
LEAn Body Mass Normalization of OXaliplatin Based Chemotherapy Pending

2024-515340-23-00 Phase II 1 country
Quality of life and neurocognitive functioning in diffuse low-grade glioma patients treated with Temozolomide: feasibility study - TEMOIN Pending

2024-516918-37-00 Phase II 1 country
Improving the empowerment in patients with severe breast fibrosis radio-induced treated by Pravastatin : benefit of e-PROs (electronic « Pat… Recruiting

2024-515342-16-00 Phase II 1 country
Study evaluating the tailored management of locally-advanced rectal carcinoma Recruiting

2024-511609-44-00 Phase II/III 1 country
Efficacy of Gembrax Followed by Folfirinox Versus Folfirinox Alone in First Metastatic Line Pancreatic Cancer Patients Recruiting

2023-508594-84-00 Phase II 1 country
STUDY TO ASSESS THE SCHEMAS OF RETREATMENT WITH LUTATHERA® IN PATIENTS WITH NEW PROGRESSION OF INTESTINAL WELL-DIFFERENTIATED NEUROENDOCRINE… Recruiting

2024-511001-28-00 Phase II 1 country L-LYSINE HYDROCHLORIDE, L-ARGININE HYDROCHLORIDE; LUTETIUM (177LU) OXODOTREOTIDE
Sequential Treatment With GEMBRAX and Then FOLFIRINOX Followed by MRI-guided Radiotherapy in Patients With Locally Advanced Pancreatic Cance… Recruiting

2024-515344-23-00 Phase II 1 country FLUOROURACIL; GEMCITABINE; IRINOTECAN HYDROCHLORIDE TRIHYDRATE; LEVOLEUCOVORIN; …
Trial assessing a regorafenib-irinotecan combination (REGIRI) versus regorafenib alone in metastatic colorectal cancer patients after failur… Ended

2024-512555-21-00 Phase III 1 country REGORAFENIB
Phase II multicenter randomized trial evaluating the association of PIPAC and systemic chemotherapy versus systemic chemotherapy alone as 1s… Ended

2024-515343-39-00 Phase II 1 country

Showing 1–10 of 10 trials

← All sponsors A–Z